July 3, 2025

Gilead Sciences Inc

FDA approves Gilead’s twice-yearly HIV prevention injection, offering a powerful and convenient new option

FDA approves Gilead’s twice-yearly HIV prevention injection, offering a powerful and convenient new option

David Bale011 mins

The Food and Drug Administration on Wednesday approved Gilead’s twice-yearly antiviral injection for preventing HIV — a milestone that the company and some experts say could help bring the world closer to ending the decadeslong epidemic caused by the virus.  But the launch of the injectable drug, which will be marketed under the name Yeztugo,…

Read More
Targeted cancer drugs may replace chemo for some patients — and drugmakers say they’re getting closer

Targeted cancer drugs may replace chemo for some patients — and drugmakers say they’re getting closer

David Bale027 mins

Antibody drug conjugates (ADCs) are targeted medicines that deliver chemotherapy agents to cancer cells 3d rendering Love Employee | Istock | Getty Images Chemotherapy has long been a cornerstone of cancer treatment, saving millions of lives. But the pharmaceutical industry says a popular class of targeted cancer therapies could one day replace chemotherapy and its…

Read More
Healthy Returns: AstraZeneca, Pfizer, Gilead and other drugmakers release promising cancer drug data at ASCO

Healthy Returns: AstraZeneca, Pfizer, Gilead and other drugmakers release promising cancer drug data at ASCO

David Bale016 mins

Attendees walk through the lobby at the American Society of Clinical Oncology annual meeting in Chicago. Tim Boyle | Bloomberg | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. I’m back in New…

Read More